CLINICAL_TRIALS
trial_result
· 2022-04-04
Clinical Trial Update: A Study of the Efficacy and Safety of ETC-1002 in Participants With Statin Intolerance [Phase 2]
Summary
Phase 2 study assessing ETC-1002 (bempedoic acid) for efficacy and safety in individuals with statin intolerance; completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Esperion Therapeutics, Inc. | Conditions: Hypercholesterolemia | Phase 2 | Status: COMPLETED | Results posted: 2022-04-04